Abstrato
Gene Expression Monitoring in Pediatric Heart Transplant recipients
S S Goonewardene and PRajjayabunAlloMap gene expression testing is a non-invasive screening tool approved for use in heart transplant recipients age 15 and older. Experience with AlloMap in pediatric heart transplant recipients is limited. We sought to describe the variations in AlloMap scores seen in pediatric heart transplant recipients.
Isenção de responsabilidade: Este resumo foi traduzido usando ferramentas de inteligência artificial e ainda não foi revisado ou verificado